Posted on 8/1/16
Celgene Corporation Nails the Second Quarter
IMAGE SOURCE: GETTY IMAGES.It's hard to find faults in Celgene's (NASDAQ:CELG) second-quarter earnings numbers. Revenue was up 21% year over year and adjusted earnings jumped 17% . . .
Posted on 8/1/16
Celgene's Otezla Is A Big Hit
IMAGE SOURCE: CELGENE CORPORATION.Celgene Corp (NASDAQ:CELG) launched Otezla in 2014 to diversify its revenue stream and by all measures, Celgene's first foray into autoimmune disease has . . .
Posted on 8/1/16
12 Big Pharma Stats That Will Blow You Away
IMAGE SOURCE: GETTY IMAGES.It only makes sense that Big Pharma would be associated with some big numbers. The size and reach of the major biopharmaceutical companies . . .
Posted on 8/1/16
AACC Launches New Journal, The Journal of Applied Laboratory Medicine
AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce the launch of its new journal, The . . .
Posted on 7/29/16
Celgene Reports Second Quarter 2016 Operating and Financial Results
SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ:CELG) reported net product sales of $2,745 million for the second quarter of 2016, a 22 percent increase from the same period . . .
Posted on 7/28/16
Key Takeaways From Johnson & Johnson's Q2 Earnings Report
Pharmaceutical giant?Johnson & Johnson?(NYSE:JNJ) reported its second-quarter financials earlier this week and results outpaced industry watchers' forecast on both the top and the bottom line. After . . .
Posted on 7/27/16
Nevakar Announces $55 Million Fundraising
Nevakar LLC, a privately-held specialty pharmaceutical company developing innovative products focused on therapies within
Posted on 7/27/16
Frontage Laboratories Announces Formation of FJ Pharma a Joint Venture with Zhejiang Jiuzhou Pharmaceutical Co
EXTON, Pa.--(BUSINESS WIRE)--Today, Frontage Laboratories, Inc. announced that it has established a joint venture with Zhejiang Jiuzhou Pharmaceutical Co., Ltd. to provide enhanced access to high . . .
Posted on 7/27/16
Data Diagnostics Healthcare Technology Wins Two Gold Honors for Innovation in the 2016 Golden Bridge Awards
Quest Diagnostics (NYSE: DGX) and Inovalon (NASDAQ: INOV) today announced that Data Diagnostics™, a point-of-care health analytics technology, has won two gold medals at the 2016 . . .
Posted on 7/27/16
The Medicines Company Reports Second-Quarter 2016 Business and Financial Results
PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company (NASDAQ:MDCO) today announced its business and financial results for the second quarter ended June 30, 2016.During the second quarter of 2016, . . .
Posted on 7/27/16
Universal Health Services Reports 2016 Second Quarter Financial Results
Universal Health Services, Inc. (NYSE: UHS) announced today that its reported net income attributable to UHS was $185.6 million, or $1.89 per diluted share, during the . . .
Posted on 7/26/16
Medifirst Solutions to Update Shareholders on Corporate and Sales Strategy
MEDIFIRST SOLUTIONS, INC. (OTC PINK: MFST) would like to update shareholders regarding its new stage of operations. As recently announced, Medifirst Solutions, Inc., in response to its . . .
Posted on 7/26/16
3 Important Takeaways From Johnson & Johnson's Second-Quarter Earnings
IMAGE SOURCE: JOHNSON & JOHNSON.Johnson & Johnson (NYSE:JNJ) is a healthcare Goliath that operates consumer healthcare, pharmaceuticals, and medical device businesses. Management recently reported second-quarter financials, . . .
Posted on 7/26/16
3 Top Biotech Stocks to Buy Now
IMAGE SOURCE: GETTY IMAGES.Back up the truck, let the tailgate down, and load up... with biotech stocks. That might seem like bad advice with many biotech . . .
Posted on 7/25/16
Sovereign Health to Open New Treatment Facility in Ashland, Pennsylvania
Sovereign Health, a leading national provider of behavioral health treatment services, is on track to open a new treatment facility in Ashland, Pennsylvania, in 2017. This . . .
Posted on 7/25/16
I Just Bought These 4 Fast-Growing Biotech Stocks
IMAGE SOURCE: GETTY IMAGES.The S&P 500 is currently trading near its all-time high, but that doesn't mean there aren't bargains on the market today. That's especially . . .
Posted on 7/25/16
3 Important Takeaways From Johnson & Johnson's Second-Quarter Earnings
IMAGE SOURCE: JOHNSON & JOHNSON.Johnson & Johnson (NYSE:JNJ) is a healthcare Goliath that operates consumer healthcare, pharmaceuticals, and medical device businesses. Management recently reported second-quarter financials, . . .
Posted on 7/25/16
Better Buy: Intuitive Surgical, Inc. vs. Johnson & Johnson
IMAGE SOURCE: GETTY IMAGES.In early May, I pitted medical conglomerate Johnson & Johnson (NYSE:JNJ) against robotic-surgery specialist Intuitive Surgical (NASDAQ:ISRG) to see which company was a . . .
Posted on 7/22/16
Madrigal Pharmaceuticals Completes Merger with Synta
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical company focused on the development
Posted on 7/22/16
Citron Pharma Launches Rosuvastatin Calcium Tablets
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Citron Pharma LLC, a rapidly growing, US based, generic pharmaceutical company confirmed that on Tuesday, July 19, its licensing partner received final approval . . .
Posted on 7/21/16
Reproductive Medicine Associates of New Jersey Opens New Office
Recently, Reproductive Medicine Associates of New Jersey (RMANJ), a world-renowned leader in the field of infertility, will welcome patients to its newest location in Marlton, New Jersey. RMANJ’s . . .
Posted on 7/21/16
BihlerMED Announces New Website Launch
PHILLIPSBURG, N.J.--(BUSINESS WIRE)--BihlerMED, a medical device company that specializes in the innovative design, development and manufacturing of surgical lighting and is the developer of the Scintillant® . . .
Posted on 7/20/16
Johnson & Johnson Keeps Growing on Pharma Strength
IMAGE SOURCE: JOHNSON & JOHNSON.Healthcare giant Johnson & Johnson (NYSE:JNJ) has been a household name for decades, with mainstays like Band-Aid and Tylenol helping to drive . . .
Posted on 7/20/16
Earnings Estimates for These 3 Biotech Giants Should Be Heading Lower -- Here's Why
IMAGE SOURCE: GETTY IMAGES.Investors have been taken for quite the wild ride in 2016. Stocks opened the year with the worst two-week start in recorded history . . .
Posted on 7/19/16
Johnson & Johnson Reports 2016 Second-Quarter Results
Johnson & Johnson (NYSE: JNJ) today announced sales of $18.5 billion for the second quarter of 2016, an increase of 3.9% as compared to the second . . .
Philadelphia
